On May 29, 2024, the ANSM (French National Agency for Medicines and Health Products Safety) announced the classification of CBD derivatives then on the market (THCP, H4CBD, HHCPO…) on the list of narcotics. No sooner said than done, but immediately banned and immediately replaced. Less than two weeks after the ban came into effect, new CBD derivatives emerged, circumventing the prohibition. Today, we present to you […]
Following our article on 10-OH-HHC, we continue our tour of CBD analogues with CBDP. Its full name is cannabidiphorol, and CBDP was discovered relatively recently, at the same time as its tetrahydrocannabinoid counterpart: THCP (or tetrahydrocannabiphorol for those in the know). For those […]
Today we're introducing you to CBDV, also known as cannabidivarin. It's a relatively unknown natural cannabinoid, but very similar to CBD. While it hasn't been studied extensively, enough has been done to warrant discussion, as it shows potentially interesting effects on several conditions: epilepsy, inflammation, neurodevelopmental discheckouts… Want to know what […]
As you've read in the article title, today we're going to talk about H2CBD. You've probably guessed it: it's a synthetic molecule created in a laboratory. It sits right between CBD and H4CBD. At least on a molecular level, because, as we'll see, in terms of bioavailability and […]
In the world of CBD, new cannabinoids are discovered almost every month. Between those found among the hundreds the plant can produce that haven't yet been cataloged, and those created from scratch or simply chemically "enhanced," there's really no time to keep up
THC acetate ester (THC-O or THCOA) is a synthetic cannabinoid that has been known for several decades. It garnered significant attention in the 1970s for its "spiritual and psychedelic" potential. Following this surge in popularity, it was banned in many countries. However, in recent years, with the relaxation of various […]
